The development of modern medicine and the combination of surgery, radiation therapy and chemotherapy have significantly improved the treatment of rhabdomyosarcoma. However, the medical community and patients still have misconceptions about the disease. 1, rhabdomyosarcoma is soft tissue sarcoma, and sarcoma is not sensitive to radiotherapy and chemotherapy. Domestic medical journals and popular science still have a large number of authors holding such a view. Rhabdomyosarcoma, especially embryonic type patients, is very sensitive to radiotherapy. About 70% of patients with rhabdomyosarcoma in all parts of the body can be cured, and more than 90% or even 100% of patients with orbital cure are reported. 2. Complete surgical excision is required to be complete. Given that rhabdomyosarcoma is sensitive to radiotherapy, complete surgical resection is not the only goal to be pursued. The greater purpose of surgery is to obtain tissue for clear pathological diagnosis and to protect the patient’s organs and functions is more important. On the basis of not damaging the patient’s function, it is necessary and feasible to remove the tumor as completely as possible.